natgillin/translations-raw huggingface dataset:
NovoMix 70 is a biphasic suspension of 70% soluble insulin aspart (rapid-acting human insulin analogue) and 30% protamine-crystallised insulin aspart (intermediate-acting human insulin analogue). 
NovoMix 70 je bifazična suspenzija sa 70% otopine aspart inzulina (brzodjelujući analog humanog inzulina) i 30% aspart inzulina kristaliziranog s protaminom (srednjedugodjelujući analog humanog inzulina).
NovoMix 30 FlexPen Glass ball 
NovoMix 30 FlexPen Staklena kuglica
How to handle NovoMix 50 FlexPen 
Kako rukovati brizgalicom NovoMix 50 FlexPen
Suspension for injection in cartridge 
Suspenzija za injekciju u ulošku
On rare occasions, injection site reactions may require discontinuation of NovoMix 30. 
Zbog reakcija na mjestu injiciranja rijetko će biti potrebno prekinuti liječenje lijekom NovoMix 30.
► After each injection, be sure to remove and discard the needle and store NovoMix 50 without the needle attached. 
Nakon svakog injiciranja iglu uvijek skinite i bacite u otpad, a potom spremite NovoMix 50 bez nataknute igle.
MARKETING AUTHORISATION NUMBERS EU/1/00/142/014 1 pen of 3 ml EU/1/00/142/015 5 pens of 3 ml EU/1/00/142/016 10 pens of 3 ml 
EU/1/00/142/014 1 brizgalica od 3 ml EU/1/00/142/015 5 brizgalica od 3 ml EU/1/00/142/016 10 brizgalica od 3 ml
NAME OF THE MEDICINAL PRODUCT NovoMix 70 Penfill 100 units/ml suspension for injection in cartridge NovoMix 70 FlexPen 100 units/ml suspension for injection in pre-filled pen 
NovoMix 70 Penfill 100 jedinica/ml suspenzija za injekciju u ulošku NovoMix 70 FlexPen 100 jedinica/ml suspenzija za injekciju u napunjenoj brizgalici
When NovoMix 30 is injected subcutaneously, the onset of action will occur within 10 to 20 minutes of injection. 
Početak djelovanja lijeka NovoMix 30 nakon supkutane injekcije nastupit će unutar 10 do 20 minuta.
Suspension for injection in pre-filled pen 50% soluble insulin aspart and 50% insulin aspart crystallised with protamine 
Suspenzija za injekciju u napunjenoj brizgalici 50% otopine aspart inzulina i 50% aspart inzulina kristaliziranog s protaminom
NovoMix 50 contains less than 1 mmol sodium (23 mg) per dose, i.e. NovoMix 50 is essentially ‘sodium-free'. 
NovoMix 50 sadrži manje od 1 mmol (23 mg) natrija po dozi, tj.
How to store NovoMix 70 
Kako čuvati NovoMix 70
NovoMix 30 is a modern insulin (insulin analogue) with both a rapid-acting and an intermediateacting effect, in the ratio 30/70. 
NovoMix 30 je moderni inzulin (inzulinski analog) s brzodjelujućim i srednjedugodjelujućim učinkom, u omjeru 30/70.
If the moving procedure alone is not enough to give a uniformly white, cloudy and aqueous liquid, repeat the rolling and moving procedures (see B and C) until the liquid does appear uniformly white, cloudy and aqueous. 
zamućena i vodena tekućina, ponovite postupak valjanja i pomicanja (vidjeti B i C) dok tekućina ne postane jednoliko bijela, zamućena i vodena.
NAME OF THE MEDICINAL PRODUCT NovoMix 50 Penfill 100 units/ml suspension for injection in cartridge NovoMix 50 FlexPen 100 units/ml suspension for injection in pre-filled pen 
NovoMix 50 Penfill 100 jedinica/ml suspenzija za injekciju u ulošku NovoMix 50 FlexPen 100 jedinica/ml suspenzija za injekciju u napunjenoj brizgalici
Before you use NovoMix 70 FlexPen, remove it from the refrigerator. 
Prije primjene lijeka NovoMix 70 FlexPen izvadite ga iz hladnjaka.
NovoMix 70 Penfill 100 units/ml 
NovoMix 70 Penfill 100 jedinica/ml
NovoMix 50 Penfill EU/1/00/142/011 EU/1/00/142/012 EU/1/00/142/013 
EU/1/00/142/011 EU/1/00/142/012 EU/1/00/142/013
It is recommended to resuspend the insulin as instructed every time you use a new pen. 
Preporučljivo je inzulin izmiješati u skladu s uputama svaki puta kad primijenite novu brizgalicu.
It is recommended to resuspend the insulin as instructed every time you use a new NovoMix 30 Penfill. 
Preporučljivo je inzulin izmiješati u skladu s uputama svaki puta kad primijenite novi NovoMix 30 Penfill.
How to use NovoMix 30 
Kako primjenjivati NovoMix 30
► FlexPen is designed to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mm. ► Always carry a spare insulin delivery device in case your FlexPen is lost or damaged. 
Uvijek sa sobom nosite rezervno pomagalo za primjenu inzulina, u slučaju da se Vaš FlexPen izgubi ili ošteti.
NovoMix 70 Penfill EU/1/00/142/017 EU/1/00/142/018 EU/1/00/142/019 
EU/1/00/142/017 EU/1/00/142/018 EU/1/00/142/019
How to store NovoMix 50 
Kako čuvati NovoMix 50
Before you use NovoMix 70 Penfill, remove it from the refrigerator. 
Prije primjene lijeka NovoMix 70 Penfill izvadite ga iz hladnjaka.
How to handle NovoMix 30 FlexPen 
Kako rukovati brizgalicom NovoMix 30 FlexPen
NovoMix 50 is presented as a suspension for injection in a pre-filled pen. 
NovoMix 50 je suspenzija za injekciju u napunjenoj brizgalici.
NAME OF THE MEDICINAL PRODUCT NovoMix 30 Penfill 100 units/ml suspension for injection in cartridge NovoMix 30 FlexPen 100 units/ml suspension for injection in pre-filled pen 
NovoMix 30 Penfill 100 jedinica/ml suspenzija za injekciju u ulošku NovoMix 30 FlexPen 100 jedinica/ml suspenzija za injekciju u napunjenoj brizgalici
► Needles and NovoMix 70 FlexPen must not be shared. 
► Igle i NovoMix 70 FlexPen ne smiju se dijeliti s drugim osobama.
Before using NovoMix 70 
Prije primjene lijeka NovoMix 70
NovoMix 70 is administered subcutaneously by injection in the thigh or in the abdominal wall. 
NovoMix 70 se primjenjuje supkutanom injekcijom u bedro ili trbušnu stijenku.
NovoMix 70 is presented as a suspension for injection in a pre-filled pen. 
NovoMix 70 je suspenzija za injekciju u napunjenoj brizgalici.
NovoMix 30 is for subcutaneous administration only. 
NovoMix 30 je namijenjen samo za supkutanu primjenu.
NovoMix 70 FlexPen 100 units/ml 
NovoMix 70 FlexPen 100 jedinica/ml
NovoMix 30 is a biphasic suspension of 30% soluble insulin aspart (rapid-acting human insulin analogue) and 70% protamine-crystallised insulin aspart (intermediate-acting human insulin analogue). 
NovoMix 30 je bifazična suspenzija sa 30% otopine aspart inzulina (brzodjelujući analog humanog inzulina) i 70% aspart inzulina kristaliziranog s protaminom (srednjedugodjelujući analog humanog inzulina).
The crystalline phase (70%) consists of protamine-crystallised insulin aspart, which has an activity profile similar to that of human NPH insulin. 
Kristalna faza (70%) sadrži aspart inzulin kristaliziran s protaminom, čiji je profil aktivnosti sličan humanom NPH inzulinu.
Before you use NovoMix 50 FlexPen, remove it from the refrigerator. 
Prije primjene lijeka NovoMix 50 FlexPen izvadite ga iz hladnjaka.
NovoMix 70 contains less than 1 mmol sodium (23 mg) per dose, i.e. NovoMix 70 is essentially ‘sodium-free'. 
NovoMix 70 sadrži manje od 1 mmol (23 mg) natrija po dozi, tj.
► Needles and NovoMix 70 Penfill must not be shared. 
► Igle i NovoMix 70 Penfill ne smiju se dijeliti s drugim osobama.
NovoMix 50 FlexPen 100 units/ml 
NovoMix 50 FlexPen 100 jedinica/ml
1 x 3 ml cartridge 5 x 3 ml cartridges 10 x 3 ml cartridges 
1 x 3 ml uložak 5 x 3 ml uložaka 10 x 3 ml uložaka
Selecting your dose 
Odmjeravanje doze
NovoMix 30 Penfill 100 units/ml 
NovoMix 30 Penfill 100 jedinica/ml
MARKETING AUTHORISATION NUMBERS EU/1/00/142/020 1 pen of 3 ml EU/1/00/142/021 5 pens of 3 ml EU/1/00/142/022 10 pens of 3 ml 
EU/1/00/142/020 1 brizgalica od 3 ml EU/1/00/142/021 5 brizgalica od 3 ml EU/1/00/142/022 10 brizgalica od 3 ml
The crystalline phase (50%) consists of protamine-crystallised insulin aspart, which has an activity profile similar to that of human NPH insulin. 
Kristalna faza (50%) sadrži aspart inzulin kristaliziran s protaminom, čiji je profil aktivnosti sličan humanom NPH inzulinu.
The crystalline phase (30%) consists of protamine-crystallised insulin aspart, which has an activity profile similar to that of human NPH insulin. 
Kristalna faza (30%) sadrži aspart inzulin kristaliziran s protaminom, čiji je profil aktivnosti sličan humanom NPH inzulinu.
► Needles and NovoMix 50 FlexPen must not be shared. 
► Igle i NovoMix 50 FlexPen ne smiju se dijeliti s drugim osobama.
NovoMix 50 FlexPen EU/1/00/142/014 EU/1/00/142/015 EU/1/00/142/016 
EU/1/00/142/014 EU/1/00/142/015 EU/1/00/142/016
NovoMix 50 Penfill 100 units/ml 
NovoMix 50 Penfill 100 jedinica/ml
Before you use NovoMix 30 FlexPen, remove it from the refrigerator. 
Prije primjene lijeka NovoMix 30 FlexPen izvadite ga iz hladnjaka.
► After each injection, be sure to remove and discard the needle and store NovoMix 30 without the needle attached. 
Nakon svakog injiciranja iglu uvijek skinite i bacite u otpad, a potom spremite NovoMix 30 bez nataknute igle.
Do not use the pen if the resuspended insulin does not look uniformly white, cloudy and aqueous. 
Nemojte koristiti uložak ako izmiješani inzulin nije jednoliko bijel, zamućen i voden.
Before using NovoMix 30 
Prije primjene lijeka NovoMix 30
Only use resuspension if uniformly white, cloudy and aqueous For use by one person only 
Mješavinu upotrijebiti samo ako je jednoliko bijela, zamućena i vodena.
Suspension for injection in pre-filled pen 70% soluble insulin aspart and 30% insulin aspart crystallised with protamine 
Suspenzija za injekciju u napunjenoj brizgalici 70% otopine aspart inzulina i 30% aspart inzulina kristaliziranog s protaminom
Uncommon - Oedema Uncommon - Injection site reactions 
Manje često - edem Manje često - reakcije na mjestu injiciranja
NovoMix 30 FlexPen 100 units/ml 
NovoMix 30 FlexPen 100 jedinica/ml
Always make sure that a drop appears at the needle tip before you inject. 
Prije injiciranja uvijek morate provjeriti je li se na vrhu igle pojavila kapljica.
NovoMix 50 is administered subcutaneously by injection in the thigh or in the abdominal wall. 
NovoMix 50 se primjenjuje supkutanom injekcijom u bedro ili trbušnu stijenku.
50% soluble insulin aspart and 50% insulin aspart crystallised with protamine 
50% otopine aspart inzulina i 50% aspart inzulina kristaliziranog s protaminom
NovoMix 70 Penfill is only suitable for subcutaneous injections from a reusable pen. 
NovoMix 70 Penfill je prikladan samo za supkutane injekcije iz brizgalice za višekratnu uporabu.
Checking the insulin flow 
Provjera protoka inzulina
NovoMix 30 is a biphasic suspension of the insulin analogue, insulin aspart. 
Način primjene NovoMix 30 je bifazična suspenzija inzulinskog analoga, aspart inzulina.
Before using NovoMix 50 
Prije primjene lijeka NovoMix 50
NovoMix 30 contains less than 1 mmol sodium (23 mg) per dose, i.e. NovoMix 30 is essentially ‘sodium-free'. 
NovoMix 30 sadrži manje od 1 mmol (23 mg) natrija po dozi, tj.
50% soluble insulin aspart and 50% insulin aspart crystallised with protamine SC use 
50% otopine aspart inzulina i 50% aspart inzulina kristaliziranog s protaminom s.c. primjena
Administration with FlexPen 
Primjena FlexPen brizgalicom
Suspension for injection in pre-filled pen 30% soluble insulin aspart and 70% insulin aspart crystallised with protamine 
Suspenzija za injekciju u napunjenoj brizgalici 30% otopine aspart inzulina i 70% aspart inzulina kristaliziranog s protaminom
► Needles and NovoMix 30 FlexPen must not be shared. 
► Igle i NovoMix 30 FlexPen ne smiju se dijeliti s drugim osobama.
Do not use the cartridge if the resuspended insulin does not look uniformly white, cloudy and aqueous. 
Nemojte koristiti brizgalicu ako izmiješani inzulin nije jednoliko bijel, zamućen i voden.
Before you use NovoMix 50 Penfill, remove it from the refrigerator. 
Prije primjene lijeka NovoMix 50 Penfill izvadite ga iz hladnjaka.
Before you use NovoMix 30 Penfill, remove it from the refrigerator. 
Prije primjene lijeka NovoMix 30 Penfill izvadite ga iz hladnjaka.
NovoMix 50 Penfill is only suitable for subcutaneous injections from a reusable pen. 
NovoMix 50 Penfill je prikladan samo za supkutane injekcije iz brizgalice za višekratnu uporabu.
NovoMix 30 is presented as a suspension for injection in a pre-filled pen. 
NovoMix 30 je suspenzija za injekciju u napunjenoj brizgalici.
NovoMix 30 Penfill is only suitable for subcutaneous injections from a reusable pen. 
NovoMix 30 Penfill je prikladan samo za supkutane injekcije iz brizgalice za višekratnu uporabu.
NovoMix 70 FlexPen EU/1/00/142/020 EU/1/00/142/021 EU/1/00/142/022 
EU/1/00/142/020 EU/1/00/142/021 EU/1/00/142/022
How to store NovoMix 30 
Kako čuvati NovoMix 30
► Needles and NovoMix 50 Penfill must not be shared. 
► Igle i NovoMix 50 Penfill ne smiju se dijeliti s drugim osobama.
NovoMix 70 FlexPen is a pre-filled pen (colour-coded) designed to be used with NovoFine or NovoTwist needles. 
NovoMix 70 FlexPen je napunjena brizgalica (označena bojom) namijenjena uporabi s iglama
NovoMix 30 is administered subcutaneously by injection in the thigh or in the abdominal wall. 
NovoMix 30 se primjenjuje supkutanom injekcijom u bedro ili trbušnu stijenku.
The remaining 70% is in crystalline form as protamine-crystallised insulin aspart; this has a prolonged absorption profile similar to human NPH insulin. 
Preostalih 70% je u kristalnoj fazi, kao aspart inzulin kristaliziran s protaminom; on ima produljen apsorpcijski profil sličan humanom NPH
► Needles and NovoMix 30 Penfill must not be shared. 
► Igle i NovoMix 30 Penfill ne smiju se dijeliti s drugim osobama.
► NovoMix 70 FlexPen is only suitable for injecting under the skin. 
► NovoMix 70 FlexPen je prikladan samo za ubrizgavanje pod kožu.
The remaining 50% is in crystalline form as protamine-crystallised insulin aspart; this has a prolonged absorption profile similar to human NPH insulin. 
Preostalih 50% je u kristalnoj fazi, kao aspart inzulin kristaliziran s protaminom; on ima produljen apsorpcijski profil sličan humanom NPH
MARKETING AUTHORISATION NUMBERS EU/1/00/142/004 5 cartridges of 3 ml EU/1/00/142/005 10 cartridges of 3 ml 
12. BROJEVI ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/00/142/004 5 uložaka od 3 ml
NovoMix 70 FlexPen is only suitable for injecting under the skin. 
NovoMix 70 FlexPen je prikladan samo za ubrizgavanje pod kožu.
NovoMix 50 FlexPen is a pre-filled pen (colour-coded) designed to be used with NovoFine or NovoTwist needles. 
NovoMix 50 FlexPen je napunjena brizgalica (označena bojom) namijenjena uporabi s iglama
Before opening: Store in a refrigerator (2°C to 8°C) During use: Do not refrigerate. 
Prije otvaranja: čuvati u hladnjaku (2°C do 8°C).
► NovoMix 50 FlexPen is only suitable for injecting under the skin. 
► NovoMix 50 FlexPen je prikladan samo za ubrizgavanje pod kožu.
► NovoMix 70 Penfill is only suitable for injecting under the skin using a reusable pen. 
► NovoMix 70 Penfill je prikladan samo za ubrizgavanje pod kožu pomoću brizgalice za višekratnu uporabu.
The remaining 30% is in crystalline form as protamine-crystallised insulin aspart; this has a prolonged absorption profile similar to human NPH insulin. 
Preostalih 30% je u kristalnoj fazi, kao aspart inzulin kristaliziran s protaminom; on ima produljen apsorpcijski profil sličan humanom NPH
NovoMix 70 Penfill is only suitable for injecting under the skin using a reusable pen. 
NovoMix 70 Penfill je prikladan samo za ubrizgavanje pod kožu pomoću brizgalice za višekratnu uporabu.
Read the following instructions carefully before using your FlexPen. 
Za dodatne informacije pročitajte upute za uporabu Vaše brizgalice.
6 seconds. 
8 mm.
► NovoMix 30 FlexPen is only suitable for injecting under the skin. 
► NovoMix 30 FlexPen je prikladan samo za ubrizgavanje pod kožu.
NovoMix 50 FlexPen is only suitable for injecting under the skin. 
NovoMix 50 FlexPen je prikladan samo za ubrizgavanje pod kožu.
141-180 mg/dl 
7,9 - 10 mmol/l 141 - 180 mg/dl
70% soluble insulin aspart and 30% insulin aspart crystallised with protamine SC use 
70% otopine aspart inzulina i 30% aspart inzulina kristaliziranog s protaminom s.c. primjena
1 ml suspension contains 100 units soluble insulin aspart/protamine-crystallised insulin aspart in the ratio 50/50 (equivalent to 3.5 mg). 
1 ml suspenzije sadrži 100 jedinica otopine aspart inzulina/aspart inzulina kristaliziranog s protaminom u omjeru 50/50 (što odgovara 3,5 mg).
30% soluble insulin aspart and 70% insulin aspart crystallised with protamine SC use 
30% otopine aspart inzulina i 70% aspart inzulina kristaliziranog s protaminom s.c. primjena
1 cartridge contains 3 ml equivalent to 300 units 
1 napunjena brizgalica sadrži 3 ml, što odgovara 300 jedinica,
Before opening: NovoMix 30 FlexPen that is not being used must be stored in the refrigerator at 2°C to 8°C, away from the cooling element. 
Prije otvaranja: NovoMix 30 FlexPen koji ne koristite morate čuvati u hladnjaku na 2°C do 8°C, dalje od rashladnih dijelova.
NovoMix 70 Penfill is designed to be used with Novo Nordisk insulin delivery systems and NovoFine or NovoTwist needles. 
NovoMix 70 Penfill je namijenjen uporabi s pomagalima za primjenu inzulina proizvođača Novo Nordisk i iglama NovoFine ili NovoTwist.
► NovoMix 50 Penfill is only suitable for injecting under the skin using a reusable pen. 
► NovoMix 50 Penfill je prikladan samo za ubrizgavanje pod kožu pomoću brizgalice za višekratnu uporabu.
NovoMix 30 FlexPen is only suitable for injecting under the skin. 
NovoMix 30 FlexPen je prikladan samo za ubrizgavanje pod kožu.
Before opening: NovoMix 70 Penfill that is not being used must be stored in the refrigerator at 2°C to 8°C, away from the cooling element. 
Prije otvaranja: NovoMix 70 Penfill koji ne koristite morate čuvati u hladnjaku na 2°C do 8°C, dalje od rashladnih dijelova.
During use or when carried as a spare: NovoMix 70 Penfill that is being used or carried as a spare should not be kept in the refrigerator. 
Tijekom uporabe ili kad se lijek nosi kao rezervni: NovoMix 70 Penfill koji koristite ili nosite kao rezervni ne smijete odlagati u hladnjak.
During use or when carried as a spare: NovoMix 70 FlexPen that is being used or carried as a spare should not be kept in the refrigerator. 
Tijekom uporabe ili kad se lijek nosi kao rezervni: NovoMix 70 FlexPen koji koristite ili nosite kao rezervni ne smijete odlagati u hladnjak.
70% soluble insulin aspart and 30% insulin aspart crystallised with protamine 
70% otopine aspart inzulina i 30% aspart inzulina kristaliziranog s protaminom
NovoMix 50 Penfill is only suitable for injecting under the skin using a reusable pen. 
NovoMix 50 Penfill je prikladan samo za ubrizgavanje pod kožu pomoću brizgalice za višekratnu uporabu.
NovoMix 30 Penfill is only suitable for injecting under the skin using a reusable pen. 
NovoMix 30 Penfill je prikladan samo za ubrizgavanje pod kožu pomoću brizgalice za višekratnu uporabu.
► NovoMix 30 Penfill is only suitable for injecting under the skin using a reusable pen. 
► NovoMix 30 Penfill je prikladan samo za ubrizgavanje pod kožu pomoću brizgalice za višekratnu uporabu.
► NovoMix 70 Penfill cartridges are designed to be used with Novo Nordisk insulin delivery systems and NovoFine or NovoTwist needles. 
► NovoMix 70 Penfill ulošci namijenjeni su uporabi s pomagalima za primjenu inzulina proizvođača Novo Nordisk i iglama NovoFine ili NovoTwist.
1 ml of the suspension contains 100 units soluble insulin aspart*/protamine-crystallised insulin aspart* in the ratio 50/50 (equivalent to 3.5 mg). 
1 ml suspenzije sadrži 100 jedinica otopine aspart inzulina*/aspart inzulina* kristaliziranog s protaminom u omjeru 50/50 (što odgovara 3,5 mg).
NovoMix 50 Penfill is designed to be used with Novo Nordisk insulin delivery systems and NovoFine or NovoTwist needles. 
NovoMix 50 Penfill je namijenjen uporabi s pomagalima za primjenu inzulina proizvođača Novo Nordisk i iglama NovoFine ili NovoTwist.
During use or when carried as a spare: NovoMix 30 Penfill that is being used or carried as a spare should not be kept in the refrigerator. 
Tijekom uporabe ili kad se lijek nosi kao rezervni: NovoMix 30 Penfill koji koristite ili nosite kao rezervni ne smijete odlagati u hladnjak.
The insulin will work more quickly if you inject around the waist. 
Ako injicirate inzulin u područje trbuha, početak djelovanja bit će brži.
NovoMix 30 Penfill is designed to be used with Novo Nordisk insulin delivery systems and NovoFine or NovoTwist needles. 
NovoMix 30 Penfill je namijenjen uporabi s pomagalima za primjenu inzulina proizvođača Novo Nordisk i iglama NovoFine ili NovoTwist.
Before opening: NovoMix 50 Penfill that is not being used must be stored in the refrigerator at 2°C to 8°C, away from the cooling element. 
Prije otvaranja: NovoMix 50 Penfill koji ne koristite morate čuvati u hladnjaku na 2°C do 8°C, dalje od rashladnih dijelova.
During use or when carried as a spare: NovoMix 50 FlexPen that is being used or carried as a spare should not be kept in the refrigerator. 
Tijekom uporabe ili kad se lijek nosi kao rezervni: NovoMix 50 FlexPen koji koristite ili nosite kao rezervni ne smijete odlagati u hladnjak.
5 x 3 ml cartridges 
5 x 3 ml uložaka 10 x 3 ml uložaka
During use or when carried as a spare: NovoMix 50 Penfill that is being used or carried as a spare should not be kept in the refrigerator. 
Tijekom uporabe ili kad se lijek nosi kao rezervni: NovoMix 50 Penfill koji koristite ili nosite kao rezervni ne smijete odlagati u hladnjak.
30% soluble insulin aspart and 70% insulin aspart crystallised with protamine 
30% otopine aspart inzulina i 70% aspart inzulina kristaliziranog s protaminom
► If the resuspended insulin does not appear uniformly white, cloudy and aqueous. 
► ako inzulin nije jednoliko bijel, zamućen i voden nakon miješanja.
► NovoMix 50 Penfill cartridges are designed to be used with Novo Nordisk insulin delivery systems and NovoFine or NovoTwist needles. 
► NovoMix 50 Penfill ulošci namijenjeni su uporabi s pomagalima za primjenu inzulina proizvođača Novo Nordisk i iglama NovoFine ili NovoTwist.
Instruction on how to use NovoMix 70 suspension for injection in FlexPen. 
Upute za uporabu NovoMix 70 suspenzije za injekciju u brizgalici FlexPen Prije uporabe brizgalice FlexPen pažljivo pročitajte ove upute.
During use or when carried as a spare: NovoMix 30 FlexPen that is being used or carried as a spare should not be kept in the refrigerator. 
Tijekom uporabe ili kad se lijek nosi kao rezervni: NovoMix 30 FlexPen koji koristite ili nosite kao rezervni ne smijete odlagati u hladnjak.
1 ml suspension contains 100 units soluble insulin aspart/protamine-crystallised insulin aspart in the ratio 30/70 (equivalent to 3.5 mg). 
1 ml suspenzije sadrži 100 jedinica otopine aspart inzulina/aspart inzulina kristaliziranog s protaminom u omjeru 30/70 (što odgovara 3,5 mg).
Before opening: NovoMix 30 Penfill that is not being used must be stored in the refrigerator at 2°C to 8°C, away from the cooling element. 
Prije otvaranja: NovoMix 30 Penfill koji ne koristite morate čuvati u hladnjaku na 2°C do 8°C, dalje od rashladnih dijelova.
Name and address of the manufacturers responsible for batch release 
11. NAZIV I ADRESA NOSITELJA ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET
► NovoMix 30 Penfill cartridges are designed to be used with Novo Nordisk insulin delivery systems and NovoFine or NovoTwist needles. 
► NovoMix 30 Penfill ulošci namijenjeni su uporabi s pomagalima za primjenu inzulina proizvođača Novo Nordisk i iglama NovoFine ili NovoTwist.
Instruction on how to use NovoMix 50 suspension for injection in FlexPen. 
Upute za uporabu NovoMix 50 suspenzije za injekciju u brizgalici FlexPen Prije uporabe brizgalice FlexPen pažljivo pročitajte ove upute.
1 ml suspension contains 100 units soluble insulin aspart/protamine-crystallised insulin aspart in the ratio 70/30 (equivalent to 3.5 mg). 
1 ml suspenzije sadrži 100 jedinica otopine aspart inzulina/aspart inzulina kristaliziranog s protaminom u omjeru 70/30 (što odgovara 3,5 mg).
Instruction on how to use NovoMix 30 suspension for injection in FlexPen. 
Upute za uporabu NovoMix 30 suspenzije za injekciju u brizgalici FlexPen Prije uporabe brizgalice FlexPen pažljivo pročitajte ove upute.
1 ml of the suspension contains 100 units soluble insulin aspart*/protamine-crystallised insulin aspart* in the ratio 30/70 (equivalent to 3.5 mg). 
1 ml suspenzije sadrži 100 jedinica otopine aspart inzulina*/aspart inzulina* kristaliziranog s protaminom u omjeru 30/70 (što odgovara 3,5 mg).
Before opening: NovoMix 70 FlexPen that is not being used must be stored in the refrigerator at 2°C to 8°C, away from the cooling element. 
Prije otvaranja: NovoMix 70 FlexPen koji ne koristite morate čuvati u hladnjaku na 2°C do 8°C,